Prior to joining Cell Biosciences, Mr Novi served as vice president of finance at Nektar Therapeutics.
The company has also appointed Robert Gavin as its new vice president of engineering, and Wilhelm Lachnit as vice president of R&D.
Most recently Mr Gavin served as director of engineering at MDS Analytical Technologies, and Dr Lachnit pioneered the early adoption of automated cell-based assays at Roche and Syntex.
Tim Harkness, president and CEO of Cell Biosciences, said: “These individuals have all been key contributors at successful life science companies. I am confident that they will provide exceptionally strong leadership as we develop our portfolio of ultra sensitive nano-proteomics products.”